Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Prabodh K. Kandala
Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors in Vitro and in Preclinical Mouse Model
PLoS ONE
Multidisciplinary
Related publications
Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Inhibition of Hemangioma Development in a Syngeneic Mouse Model Correlates With BCL-2 Suppression and the Inhibition of Akt Kinase Activity
Angiogenesis
Cancer Research
Clinical Biochemistry
Physiology
Human Ovarian Tumors of Epithelial Origin Express PDGF in Vitro and in Vivo
Cancer Genetics and Cytogenetics
SKA3 Promotes Lung Adenocarcinoma Metastasis Through the EGFR-PI3K-Akt Axis
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
EGFR Inhibition Prevents in Vitro Tumor Growth of Salivary Adenoid Cystic Carcinoma
BMC Cell Biology
Cell Biology
Lidocaine Inhibits the Progression of Retinoblastoma In�vitro and In�vivo by Modulating the miR‑520a‑3p/EGFR Axis
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Tankyrase Inhibition Enhances the Anti-Proliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting Β-Catenin and AKT Signaling in Colorectal Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
CXCR2 Inhibition Combined With Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
PLoS ONE
Multidisciplinary
Targeting of Both the C-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice
Cancers
Cancer Research
Oncology
